Newsletters - July 1997

Newsletters - July 1997

Star InactiveStar InactiveStar InactiveStar InactiveStar Inactive
 

Boswellic acids, the biologically active ingredients of Boswellia serrata gum resin, are used to treat inflammatory disorders.

A recent report published in the European Journal of Medical Research (Jan 20, 1997) showed that treatment with Boswellia serrata gum resin induced remission of symptoms in 82% of the ulcerative colitis patients studied. This treatment compared favorably with conventional treatment using NSAIDS.

Boswellin® supplied by Sabinsa Corporation is standardized for 70% boswellic acids.

    VISIT US

  • Sabinsa Europe GmbH
    Monzastrasse 4
    63225 Langen
    Germany

  • +49 6103 270 11 11
  • +49 6103 270 11 27
  • info@sabinsa.eu

CERTIFICATES

Certificate Logos
Certificate Logos
Certificate Logos
Certificate Logos
Certificate Logos

CONTACT US